Nakamura M, Miyamoto S, Maeda H, Zhang S, Sangai T, Ishii G, Hasebe T, Endoh Y, Saitoh N, Asaka M, Ochiai A.

Low levels of insulin-like growth factor type 1 receptor expression can predict the hepatic metastasis in Dukes’ C human colorectal cancers.

Clin Cancer Res 2004;10:8434-41

Goya M, Miyamoto S, Ohki Y, Nakamura K, Shitara K, Maeda H, Sangai T, Kodama K, Endoh Y, Ishii G, Hasebe T, Nagai K, Yonou H, Hatano T, Ogawa Y, Ochiai A.

Growth inhibition of human prostate cancer cells in human adult bone implanted into non-obese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.

Cancer Res 2004;64:6252-8

Miyamoto S, Endoh Y, Hasebe T, Ishii G, Kodama K, Goya M, Ono M, Saitoh N, Chiba T, Ochiai A.

Nuclear ?-catenin accumulation as a prognostic factor in Dukes’ D human colorectal cancers.

Oncol Rep 2004;12:245-51

Miyamoto S, Yano K, Sugimoto S, Ishii G, Hasebe T, Endoh Y, Kodama K, Goya M, Chiba T, Ochiai A.

Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.

Cancer Res 2004;64:665-71

Lim SC, Zhang S, Ishii G, Endoh Y, Kodama K, Miyamoto S, Hayashi R, Ebihara S, Cho JS, Ochiai A.

Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue.

Clin Cancer Res 2004;10:166-72.

Kusakai G, Suzuki A, Ogura T, Miyamoto S, Ochiai A, Kaminishi M, Esumi H.

ARK5 expression in colorectal cancer and its implications for tumor progression.

Am J Pathol 004;164:987-95.

Suzuki A, Kusakai G, Kishimoto A, Shimojo Y, Miyamoto S, Ogura T, Ochiai A, Esumi H.

Regulation of caspase-6 and FLIP by the AMPK family member ARK5.

Oncogene 2004;23:7067-75.